Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II–IIIA (8th edition TNM classification) primary lung cancer after curative surgery-Reference-Cited by-同舟云学术

Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II–IIIA (8th edition TNM classification) primary lung cancer after curative surgery

Published:2021-12 Issue: Volume:162 Page:128-134
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Isaka Tetsuya,Ito Hiroyuki,Nakayama Haruhiko,Yokose Tomoyuki,Saito Haruhiro,Adachi Hiroyuki,Miura Jun,Shigefuku Shunsuke,Kikuchi Akitomo,Rino Yasushi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc. Natl. Acad. Sci. U.S.A.,2004

2. Japanese Joint Committee of Lung Cancer Registry. Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases;Suda;Ann. Thorac. Surg.,2021

3. RET fusion gene: translation to personalized lung cancer therapy;Kohno;Cancer Sci.,2013

4. Cancer. Addiction to oncogenes-the Achilles heal of cancer;Weinstein;Science,2002

5. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence;Mitsudomi;J. Clin. Oncol.,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of predominant subtype in pathological stage II–III lung adenocarcinoma with epidermal growth factor receptor mutation;Lung Cancer;2024-02

2. Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma;Interdisciplinary CardioVascular and Thoracic Surgery;2023-10-31

3. Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1–N2 epidermal growth factor receptor mutant lung adenocarcinoma;Translational Lung Cancer Research;2023-10

4. Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study;Journal of Cancer Research and Clinical Oncology;2023-03-16

5. Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status;BMC Cancer;2022-09-09